Issues related to drug pricing
2026 · 1st Quarter (Jan 1 - Mar 31)
GILEAD SCIENCES, INC.
Filed by THE DUBERSTEIN GROUP INC..
Open official filingSource-reported fields
Filing overview
- Type
- 1st Quarter - Report
- Posted
- Apr 20, 2026
- Income
- $90,000.00
- Expenses
- Not reported
- Registrant
- THE DUBERSTEIN GROUP INC.
- Client
- GILEAD SCIENCES, INC.
- Filing UUID
- b4aa67de-2daa-4ec0-a3b7-b2c1b6a191aa
- Termination date
- Not reported
Literal source text
Lobbying issues and bill citations
Relationship and amount limits
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.